MedRhythms announced that it received a final pricing determination from CMS for its InTandem rehabilitation system.

December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by end of January-- --The stroke registrational program is intended to demonstrate the ...

MedRhythms, Inc. today announced that InTandem®, the company's flagship rehabilitation system for chronic stroke gait impairment, received a final pricing determination from the Centers for Medicare ...

Doncaster and Bassetlaw Teaching Hospitals (DBTH) have marked an exciting milestone with the start of a pioneering new ...

Doncaster and Bassetlaw Teaching Hospitals (DBTH) have marked an exciting milestone with the start of a pioneering new ...

The UPV/EHU's COMPMECH research group has patented a mechatronic instrument that uses a mobile platform to stimulate a ...

Updated guidelines for stroke rehabilitation, developed jointly by the U.S. Department of Veterans Affairs and the U.S.

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $2.8 ...

Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced it has exceeded its initial enrollment target for the stroke registrational program evaluating its Portable Neuromodulation Stimulator (PoNS® ...